Advances in Hybrid Polymer-Based Materials for Sustained Drug Release

Table 1

Blended polymers as pharmaceutical forms for DDS discussed here.

Polymeric blend	Form	Drug	Ref.
PLGA-PEG	Micelle	Doxorubicin	[4]
Chitosan-alginate	Beads	BSA	[16]
Chitin-Pluronic F108	Microparticles	Paclitaxel	[20]
Chitosan-gelatin	Hydrogel	Chloramphenicol	[22]
Chitosan-alginate	Microcapsules	Nitrofurantoin	[25]
Chitosan-glucomannan	Hydrogel	Ofloxacin	[26]
Chitosan-silk fibroin	Film	Theophylline	[27]
Chitosan-silk fibroin	Film	Sodium diclofenac	[27]
Chitosan-silk fibroin	Film	Amoxicillin	[27]
Chitosan-silk fibroin	Film	Salicylic acid	[27]
Alginate-gelatin	Film	Ciproflaxin	[29]
Alginate-zein	Beads	Ibuprofen	[32]
Chitosan-pectin	Beads	5-Aminosalicylate	[33]
PEG-gelatin	Nanoparticles	Ibuprofen	[34]
PEG-gelatin	Hydrogel	Ciproflaxin	[34]
PLGA-gelatin	Nanofiber	Fenbufen	[34]